Commentary on: Reduced Pain and Accelerated Recovery Following Primary Breast Augmentation With Lightweight Breast Implants

摘要

I enjoyed reading the paper entitled “Reduced Pain and Accelerated Recovery Following Primary Breast Augmentation With Lightweight Breast Implants” and congratulate the authors for collating this information. Like many I have been aware of this novel implant style for a number of years and have keenly waited for the appearance of published clinical information. The senior author is the President of G&G Biotechnology Ltd (Haifa, Israel) and has previously published “Lightweight Breast Implants: A Novel Solution for Breast Augmentation and Reconstruction Mammaplasty” on the B-Lite lightweight breast implant (LWBI) (G&G Biotechnology Ltd) in 2015. At that time the purpose of the paper was to introduce the theory that breast implant weight, rather than size alone, is a crucial determinant of long-term clinical outcomes. They talked about breast composition and the response to mechanical forces that may contribute to permanent tissue deformities, breast tissue atrophy, accelerated ptosis, and inframammary fold breakdown. They talked about the development, composition, and testing of a novel breast implant design which allows for a reduction in implant weight of 25% to 30% while maintaining the size, form, and function of traditional breast implants. It is projected that this would reduce the inherent strains imposed by standard full weight breast implants and minimize some of the secondary issues that can develop with time.